The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions
Open accessAbstract
After publication of the updated World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues in 2008, the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph) now presents an update of the hierarchical classification of lymphoid neoplasms for epidemiologic research based on the 2001 WHO classification, which we published in 2007. The updated hierarchical classification incorporates all of the major and provisional entities in the 2008 WHO classification, including newly defined entities based on age, site, certain infections, and molecular characteristics, as well as borderline categories, early and “in situ” lesions, disorders with limited capacity for clinical progression, lesions without current International Classification of Diseases for Oncology, 3rd Edition codes, and immunodeficiency-associated lymphoproliferative disorders. WHO subtypes are defined in hierarchical groupings, with newly defined groups for small B-cell lymphomas with plasmacytic differentiation and for primary cutaneous T-cell lymphomas. We suggest approaches for applying the hierarchical classification in various epidemiologic settings, including strategies for dealing with multiple coexisting lymphoma subtypes in one patient, and cases with incomplete pathologic information. The pathology materials useful for state-of-the-art epidemiology studies are also discussed. We encourage epidemiologists to adopt the updated InterLymph hierarchical classification, which incorporates the most recent WHO entities while demonstrating their relationship to older classifications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“North American registries define multiple primary cancers under the rules of the Surveillance Epidemiology and End Results (SEER) programme.22 Those rules accept more cancers as new primary cancers than the rules of the International Association of Cancer Registries (IACR),23 which are used by most cancer registries in other continents.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationEgner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 6,011
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,950
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,614
Hans, C. P. (2003) · Blood · doi:10.1182/blood-2003-05-1545 · Cited by 4,270
Rosenwald, A., Wright, G. W., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Müller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,832
Self-citationA review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Research works printed but not linked: 3
- Percy, 2001, Conversion of neoplasms by topography and morphology from the International Classification of Diseases for Oncology, second edition, to International Classification of Diseases for Oncology
- Horner, SEER Cancer Statistics Review, 1975-2006, National Cancer Institute.
- Johnson, 2010, Hematopoietic and Lymphoid Neoplasm Case Reportability and Coding Manual
Cited by
Sorted by citations
Items 201–231 of 231
Lech‐Marańda, E., Budziszewska, B. K., Mikolajczyk, T. P., Więckowska, B., Dagiel, J., & Wiktor-Jędrzejczak, W. (2022) · Acta Haematologica Polonica · doi:10.5603/ahp.2022.0011 · Cited by 2
Levin, L. I., Ramirez, C. M., Liao, E. L., Guo, H., Kim, B. K., Marrogi, A. J., Magpantay, L. I., Breen, E. C., & Martı́nez-Maza, O. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0247 · Cited by 1
Alcohol and Cancer: The Epidemiological Evidence
Ferrari, P., Rumgay, H., Weiderpass, E., & Soerjomataram, I. (2023) · Springer eBooks · doi:10.1007/978-3-031-32483-3_74 · Cited by 1
Almanza‐Aguilera, E., Guananga-Álvarez, D., Benavente, Y., Nieters, A., Besson, C., Hosnijeh, F. S., Kyrø, C., Bondonno, N. P., Dahm, C. C., Weiderpass, E., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03228-6 · Cited by 1
Guo, Y., Zhong, Y., Zhu, L., Zhou, F., Lin, X., Li, X., Wang, X., Huang, Y., Sun, Z., Lv, G., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1689028 · Cited by 1
Identifying genes and pathways in familial lymphoid cancers using whole exome sequencing
Ralli, S., Jones, S. J., Leach, S. R., Lynch, H., & Brooks-Wilson, A. R. (2026) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2026.2624656 · Cited by 1
“Based on the InterLymph classification, lymphoid neoplasms can be grouped into three main types: Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), and other lymphoproliferative disorders [1].”
van de Schans, S. A. M., Strobbe, L. S., Holst, I., Meijer, J. W. R., Mattijssen, V., de Kievit, I. M., Mandigers, C. M. P. W., Raemaekers, J. M. M., Aben, K. K. H., & van Krieken, J. H. (2013) · Journal of Hematopathology · doi:10.1007/s12308-013-0196-6 · Cited by 1
“pathologic schemes used to classify lymphomas and lymphoid leukemias [2, 3].”
BackgroundMeloni, F., Benavente, Y., Becker, N., Casabonne, D., Foretová, L., Maynadié, M., Nieters, A., Staines, A. S., Trobbiani, C., Pilia, I., et al. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102495 · Cited by 1
Self-citationLi, X., Luo, R., Xu, J., Jin, X., Wang, W., Xiao, X., & Qian, W. (2025) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300941 · Cited by 1
“Intravascular large B-cell lymphoma (IVLBCL), a rare subtype of non-Hodgkin lymphoma, is classified as an independent subtype of extranodal diffuse large B-cell lymphoma (DLBCL) in the 2008 World Health Organization (WHO) Classification (Turner et al., 2010).”
Al-Taee, Z. M., Zamil, R. H., Al-kattan, S. D. S., Al-kaabi, M. M., & Kamal, A. M. (2025) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v8i2.1960 · Cited by 1
Cabrera-Serrano, A. J., Sánchez‐Maldonado, J. M., Rodríguez‐Sevilla, J. J., Reyes‐Zurita, F. J., Collado, R., Puiggros, A., Cornejo-Calvo, E., García-Martín, P., ter Horst, R., Benavente, Y., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025017345 · Cited by 1
Self-citationOccupational exposure to extremely low frequency magnetic fields and the risk of chronic diseases
Koeman, T. (2014) · Utrecht University Repository (Utrecht University)
Lymphoma Prevalence Patterns in Uganda, 1969-2006
Kamulegeya, A., & Muwazi, L. M. (2013) · DOAJ (DOAJ: Directory of Open Access Journals)
Plummer, K. H. (2014) · Digital Commons - University of South Florida (University of South Florida)
RE: The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study
Engels, E. A., Parsons, R., Besson, C., Morton, L. M., Yanik, E. L., Arem, H. E., & Pfeiffer, R. M. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx026
“1 of 2 JNCI J Natl Cancer Inst (2017) 109(4): djx026”
BackgroundSelf-citationBrånvall, E. (2020) · Figshare
Vainchenker, W., & Plo, I. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738193794.793578394
van Leeuwen, M. T., & Vajdic, C. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.02753-7
Self-citationvan Krieken, J. H. (2010) · Journal of Hematopathology · doi:10.1007/s12308-010-0078-0
“The 2007 InterLymph system is now updated and can indeed serve as such [15].”
van Leeuwen, M. T., & Vajdic, C. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803678-5.00264-2
Self-citationLymphosarcoma Incidence in Kazakhstan: A Retrospective Survey (2010-2019)
Bayembayev, F., Rakhimzhanova, R., Dautov, T., Saduakasova, A., Telmanova, Z., Билялова, З. А., & Igissinov, N. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.6.1885
“Lymphosarcoma covers more than 40 lymphoid malignancies of various molecular origin, differing in clinical picture and prognosis, which range from very indolent to very aggressive (Turner et al., 2010).”
BackgroundShared and distinct aspects of hematopoietic malignancies such as leukemia and lymphoma
Iyshwarya, B. K., & Veerabathiran, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95114-2.00024-8
Adel, A. M., Exarchakou, A., ElShafey, N., Ghazouani, H., Alshurafa, A., & Yassin, M. A. (2024) · Oncology · doi:10.1159/000536567
Panda, P. K., & Tan, D. S.-W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00256-8
Duan, X., He, W., Chen, R., Jing, M., & Wang, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1629134
Wyss, K., Granath, F., Wångdahl, A., Djärv, T., Fored, M., Nauclér, P., & Färnert, A. (2020) · Figshare · doi:10.6084/m9.figshare.13167392
Andera, L. F., Chetty, D. R., Mohamed, Z., Oelofse, D., Bailey, J., Brown, K. L., Panchoo, G., Antel, K. R., Simba, K., Kritzinger, G., et al. (2026) · BMC Cancer · doi:10.1186/s12885-026-15807-8
Metadata
- Authors
- Turner, J. J., Morton, L. M., Linet, M. S., Clarke, C. A., Kadin, M. E., Vajdic, C. M., Monnereau, A., Maynadié, M., Chiu, B. C.-H., Marcos-Gragera, R., Costantini, A. S., Cerhan, J. R., & Weisenburger, D. D.
- Affiliations
- Douglass Hanly Moir Pathology (AU)
- National Institutes of Health (US)
- Cancer Prevention Institute of California (US)
- Boston University (US)
- UNSW Sydney (AU)
- Inserm (FR)
- Université de Bourgogne (FR)
- University of Chicago (US)
- Epidemiology Unit, Cancer Registry of Girona, Oncology Planning, Department of Health, Institute of Biomedical Investigation, Girona, Spain;
- Cancer Research and Prevention Institute Epidemiology, Florence, Italy;
- Mayo Clinic (US)
- University of Nebraska Medical Center (US)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2010-11-18
- Volume
- 116
- Issue
- 20
- Pages
- e90-e98
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC2993636
- OpenAlex
- W2070728536
- Cited by
- 231
- References
- 45
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 19 · 2019: 11 · 2018: 15 · 2017: 7 · 2016: 18 · 2015: 25 · 2014: 39 · 2013: 25 · 2012: 16
- FWCI
- 10.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services
- National Institutes of Health (CA97274)
- National Cancer Institute (CA97274, R01 CA97274, R01CA092153, P50CA097274)
- National Center for Research Resources (P20RR018757)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Hematology › Hematological disorders and diagnostics
- Keywords
- lymphoid malignancies, hierarchical classification, lymphoma epidemiology, lymphoma subtypes, primary cutaneous T-cell lymphoma
- MeSH terms
- Humans, Lymphoma, Societies, Medical, World Health Organization, Epidemiologic Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
